C-reactive protein and emergency department seven days revisit-Reference-Cited by-同舟云学术

C-reactive protein and emergency department seven days revisit

Published:2018-06 Issue: Volume:481 Page:207-211
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Ziv-Baran Tomer^ORCID,Wasserman Asaf,Shteinvil Ronen^ORCID,Zeltser David,Shapira Itzhak,Shenhar-Tsarfaty Shani,Meilik Ahuva,Goldiner Ilana,Rogowski Ori,Berliner Shlomo,Halpern Pinchas

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference29 articles.

1. The C-reactive protein;Clyne;J. Emerg. Med.,1999

2. The value of C-reactive protein in emergency medicine;Su;J. Acute Dis.,2014

3. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes;Cameron;Clin. Chim. Acta,2007

4. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation;Rogowski;Clin. Chim. Acta,2005

5. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study);Pan;Clin. Chim. Acta,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes after ED visit for acute Chest Pain, with respect to negative but measurable troponin levels and CRP levels;2024-02-08

2. Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis;Medicine;2023-11-10

3. Factors influencing recurrent emergency department visits for mild acute respiratory tract infections caused by the influenza virus;PeerJ;2023-10-06

4. Biological properties of bioactive compounds from the fruit and leaves of the genipap tree (Genipa americana L.): A systematic review;Food Bioscience;2023-06

5. Reduced C-reactive protein level at hospital admission in patients treated with Tocilizumab – An attention may be required;Heliyon;2023-06